Skip to content

Merck Sues Over Medicare Drug-Price Negotiation Law

Image by Thanks for your Like • donations welcome from Pixabay

Written by

Rebecca Robbins

in

The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.

Author: Rebecca Robbins

Share this:

X
Facebook
Email
Print
More

LinkedIn
Reddit
Tumblr

Drugs (Pharmaceuticals) Health Insurance and Managed Care Inflation Reduction Act of 2022 Medicare Merck & Company Inc Prices (Fares, Fees and Rates) Suits and Litigation (Civil)

←SEC Sues Coinbase, Accuses Crypto Platform of Breaking Market Rules

World Bank Projects Weak Global Growth Amid Rising Interest Rates→

Comments

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts

The Wife of Haiti’s Assassinated President Is Accused in His Killing

February 19, 2024
Israeli military operations reduce the functioning of two hospitals in southern Gaza to nearly nothing.

February 19, 2024
Brazil’s President Lula Recalls Ambassador to Israel, Escalating a Dispute

February 19, 2024
On Tom Suozzi and the Long Island Special Election

February 19, 2024

VOXYVOTE

The Voice and Choice of the People

Blog
About
FAQs
Authors

Events
Shop
Patterns
Themes

Twenty Twenty-Five

Designed with WordPress

<
<
<
<

Change Location

Find awesome listings near you!

Change Location